Centene Corp
Centene
CNC · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $174.6B
- Assets
- $76.7B
- SEC filing
- DEF 14A
- Filed
- March 26, 2026
Executive Compensation
Compensation reported for Centene’s named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Sarah M. London
Chief Executive Officer
$19.5M
Reported total
- Salary
- $1,473,077
- Stock awards
- $15,537,733
- Incentives
- $2,109,446
- Option awards
- $0
- Other
- $386,042
Andrew L. Asher
Chief Financial Officer
$16.1M
Reported total
- Salary
- $1,152,885
- Stock awards
- $13,362,923
- Incentives
- $1,238,198
- Option awards
- $0
- Other
- $318,874
Christopher A. Koster
Secretary And General Counsel
$6.5M
Reported total
- Salary
- $768,269
- Stock awards
- $5,111,079
- Incentives
- $550,081
- Option awards
- $0
- Other
- $79,364
Susan R. Smith
Chief Operating Officer
$4.9M
Reported total
- Salary
- $718,269
- Stock awards
- $3,577,782
- Incentives
- $514,281
- Option awards
- $0
- Other
- $76,751
Tanya McNally
Chief People Officer
$3.2M
Reported total
- Salary
- $654,808
- Stock awards
- $1,967,756
- Incentives
- $468,843
- Option awards
- $0
- Other
- $80,949
Sarah M. London
Chief Executive Officer
$19.5M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed March 26, 2026.
- Salary
- $1.5M
- Stock Awards
- $15.5M
- Incentives
- $2.1M
- Other
- $386K
Historical Compensation
Sarah M. London total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,473,077 | $15,537,733 | $19,506,298 |
| 2024 | $1,400,000 | $14,630,132 | $20,602,148 |
| 2023 | $1,400,000 | $13,573,031 | $18,556,966 |
Named Executive Officers
Sarah M. London
Chief Executive Officer
Centene · CNC
$19.5M
FY 2025 · DEF 14A
Andrew L. Asher
Chief Financial Officer
Centene · CNC
$16.1M
FY 2025 · DEF 14A
Christopher A. Koster
Secretary And General Counsel
Centene · CNC
$6.5M
FY 2025 · DEF 14A
Tanya McNally
Chief People Officer
Centene · CNC
$3.2M
FY 2025 · DEF 14A
Susan R. Smith
Chief Operating Officer
Centene · CNC
$4.9M
FY 2025 · DEF 14A
Source information
- Company
- Centene Corp
- Ticker
- CNC · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- March 26, 2026
- SEC accession number
- 0001071739-26-000077
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company →
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company →
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company →
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company →